Does Rallies show NGNE price targets?

Yes. Rallies tracks NGNE analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.

Is NGNE research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NGNE. It does not provide personalized investment advice.

NGNE (Neurogene, Inc. Common Stock) Stock Analysis - Analyst Ratings

Neurogene, Inc. Common Stock (NGNE) is a publicly traded Healthcare sector company. As of October 5, 2026, NGNE trades at $26.46 with a market cap of $513.29M and a P/E ratio of -6.04. NGNE moved +3.31% today. Year to date, NGNE is +28.50%; over the trailing twelve months it is +18.49%. Its 52-week range spans $6.88 to $43.66. Analyst consensus is strong buy with an average price target of $84.20. Rallies surfaces NGNE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate NGNE?

7 analysts cover NGNE: 0 strong buy, 7 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $84.20.

NGNE Key Metrics

Key financial metrics for NGNE
Metric	Value
Price	$26.46
Market Cap	$513.29M
P/E Ratio

EPS	$-4.24

Dividend Yield	0.00%

52-Week High	$43.66

52-Week Low	$6.88

Volume	184.40K

Avg Volume	0

Revenue (TTM)	$0

Net Income	$-90.35M

Gross Margin	0.00%

Common questions about NGNE

What do analysts rate NGNE?: 7 analysts cover NGNE: 0 strong buy, 7 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $84.20.
Does Rallies show NGNE price targets?: Yes. Rallies tracks NGNE analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is NGNE research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NGNE. It does not provide personalized investment advice.

Neurogene

Analysts

Neurogene

Analysts

NGNE Analyst Consensus

Common questions about NGNE